Patient Preference and Satisfaction Ultimately, the choice between Semaglutide and other treatments depends on individual patient factors, including the severity of their condition, their tolerance for side effects, and their personal health goals
You build the platform so the incentives push money toward the drug and toward the patient rather than into administrative overhead
Microdosing is still a prescription GLP-1, but at a small dose
The motivation is gone because it no longer induces the same reward it did, which I think the only way around that, if the person really needs the medication, is to have either external ways of being motivated, such as having a trainer who goes, Get out there and do your lifting, or, enough internal sense of, I need to do this because it's good for me, not because it feels good anymore. Which is a very difficult position
In addition, cardiovascular disease is the main cause of death in patients with diabetes (6, 7)
Telehealth platforms like Heally make it easy to maintain that connection, allowing you to consult with your provider from the comfort of your home